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Abstract
Purpose When considering malaria disease severity, estimation of parasitemia in erythrocytes is important, but sometimes 
misleading, since the infected erythrocytes may be sequestered in peripheral capillaries. In African children and Asian adults 
with falciparum malaria, parasitemia as assessed by quantitative PCR (qPCR) in plasma seems to be a valuable indicator of 
disease severity, but data on African adults as well as the impact of co-infection with HIV is lacking.
Methods In 131 patients with falciparum malaria in a public tertiary teaching hospital in Mozambique, plasma malaria 
parasitemia as assessed by qPCR, compared to qualitative malaria PCR in blood cell fraction, was related to malaria disease 
severity and HIV co-infection.
Results Of the 131 patients with falciparum malaria, based on positive qualitative PCR in the blood cell fraction, 93 patients 
(72%) had positive malaria qPCR in plasma. Patients with severe malaria as defined by the WHO criteria had higher malaria 
quantitative plasma parasitemia (median 143 genomes/µL) compared to those with uncomplicated malaria (median 55 
genomes/µL, p = 0.037) in univariate analysis, but this difference was attenuated after adjusting for age, sex and HIV co-
infection (p = 0.055). A quarter of the patients with severe malaria had negative qPCR in plasma.
Conclusions This study of adult African in-patients with falciparum malaria with and without HIV co-infection, neither 
confirms nor rejects previous studies of malaria qPCR in plasma as an indicator of disease severity in patients with falciparum 
malaria. There is a need for further and larger studies to clarify if parasitemia as assessed malaria qPCR in plasma could be 
a surrogate marker of disease severity in falciparum malaria.
Keywords Falciparum malaria · Severe malaria · Quantitative plasma PCR · qPCR · Malaria disease severity · HIV 
co-infection · Mozambique
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Introduction
In spite of decreasing incidence, falciparum malaria still 
causes about half a million fatalities every year, whereof 
93% occur in sub-Saharan Africa and about two thirds 
are children below 5 years of age [1]. When considering 
disease severity in malaria patients, estimation of the para-
sitemia in the erythrocytes is important, but sometimes 
misleading. Thus, a low-level parasitemia as assessed by 
blood smear evaluation may be (1) an indicator of uncom-
plicated malaria, (2) an asymptomatic malaria carrier suf-
fering from another potential severe infection, particularly 
in patients with HIV (human immunodeficiency virus) co-
infection, or of (3) severe malaria with peripheral seques-
tration of the infected erythrocytes [2, 3].
In African children in a moderate-to-high transmis-
sion area, histidine-rich-protein 2 (HRP 2)-concentration 
in plasma distinguished severe malaria from coinciden-
tal parasitemia due to carrier state [4]. Similar, a multi-
centre study of Asian adults and African children found 
that plasma HRP2 was a better indicator of severe malaria 
compared to parasite densities by microscopy (thick and 
thin slides). The same applied when they compared plasma 
parasitemia as assessed by qPCR (quantitative malaria 
polymerase chain reaction) methods to the mentioned 
microscopy [5]. Currently there are several published 
DNA (deoxyribonucleic acid) based qPCR methods for 
quantitation of P. falciparum [6]. Most of these meth-
ods are highly sensitive for detection of malaria and can 
detect the parasite even at very low levels (i.e., 0.03 para-
sites/µL present in blood) [6, 7], reflecting that most of 
the methods target a multi-copy gene e.g. mitochondria 
20–160 copies per genome [8], TARE-2 250–280 copies 
per genome [9]. This means that a sensitive PCR has the 
potential to detect low density of malaria DNA produced 
by premunition, early infections, dormant stages, game-
tocytes, persistent clones, and destroyed parasites [10]. 
Therefore, highly sensitive methods are best for the pur-
pose of detection and elimination of malaria. On the other 
hand, when measuring malaria severity, a method with 
high specificity is more preferable, even if it should be 
less sensitive. The mentioned Imwong study used a qPCR 
method targeting 18S ribosomal RNA. This gene target 
exists in five to eight copies per genome [6]. However, 
they examined African children and Asian adults and they 
did not consider HIV co-infection, which is an important 
factor in relation to disease severity in falciparum malaria 
[11–13]. We have previously reported outcome data and 
markers of inflammation in a cohort of adult patients with 
falciparum malaria with and without co-infection with 
HIV from Mozambique [12, 14]. Herein, we analysed the 
relationship between quantitative parasite DNA in plasma 
as a surrogate marker of parasitemia and clinical disease 
severity in patients with falciparum malaria with and with-
out co-infection with HIV.
Materials and methods
Study design and participants
The study design has previously been described [12]. Briefly, 
clinical data and blood samples were collected prospectively 
on admission from all (n = 212) patients consecutively 
admitted during regular work hours during weekdays during 
two malaria seasons from January to March 2011 and from 
November 2011 to March 2012 in the Central Hospital of 
Maputo, Mozambique [12]. Inclusion criteria were age ≥ 18 
years, negative pregnancy test in women in fertile age, axil-
lary temperature ≥ 38 °C and/or clinical suspected malaria 
and written or fingerprinted informed consent from patient 
or if mentally confused or unconscious patient, from next 
of kin. “Clinical suspicion of malaria” was defined when 
the patient had a history of fever, chills, headache, mental 
confusion, dyspnoea, vomiting and/or diarrhoea, myalgia 
and/or general malaise in the absence of other symptoms 
and findings upon clinical examination or additional tests 
indicating other severe infections or conditions. Exclusion 
criteria were age < 18 years, pregnancy or mental confusion 
without relatives present to give consent. Baseline character-
istics of the malaria patients are given in Table 1. Details on 
the study population, clinical data collection and additional 
examinations are described elsewhere [12].
Procedures
The blood samples were collected from a pre-alcohol-
cleaned peripheral vein into pyrogenic-free tubes with 
EDTA (Ethylene-diamine-tetra-acetic acid). The EDTA 
vacutainer tubes were turned gently, placed immediately on 
melting ice, and centrifuged within 30 min at 2000 rpm for 
20 min. Plasma was aliquoted and stored first at − 20 °C for 
24 h; then at − 80 °C until further analyses. The remaining 
blood cell fraction was also stored at − 80 °C. From this, we 
later purified the total nucleic acids using a MagNA Pure 
(Roche) robot and analysed with a qualitative PCR analysis 
for Plasmodium, HIV-1 and HIV-2.
According to the hospital’s routine and consistent with 
the standard procedures in the hospital’s laboratory, we per-
formed malaria antigen test (HRP-2 Rapid Diagnostic Test 
(RDT)) for malaria in 2010–2011 using First Response® 
Malaria antigen P. falciparum, Premium Medical Corpo-
ration Ltd., Daman, India and in 2011–2012 ICT Malaria 
P.f.®, using ICT Diagnostics Cape Town, South Africa, 
thick smears (Giemsa 20% for 5  min) and HIV testing 
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(Determine, Alere Medical Co. Ltd; Chiba, Japan and Uni-
gold, Trinity Biotech plc, Bray, Ireland) and other routine 
blood tests (Haemoglobin, WBC, platelets, creatinine, bili-
rubin, AST, ALT, ALP and ESR).
Severe malaria was defined according to WHO (World 
Health Organization) criteria [15] and adjusted for what was 
possible to observe or measure in this clinical setting, i.e. 
one or more of the following nine severity criteria: Anemia 
with haemoglobin < 5 g/dL, observed bleeding disturbances 
or haemolysis, hypoglycaemia with glucose ≤ 2.2 mmol/L, 
renal failure with creatinine > 265 µmol/L, liver failure with 
observed jaundice or bilirubin > 50 µmol/L, signs of cer-
ebral malaria with Glasgow Coma Scale < 11 and/or con-
vulsions/confusion, hypotension with systolic blood pres-
sure < 80 mmHg, signs of respiratory failure with respiratory 
rate > 30 and/or chest X-ray indicating respiratory insuffi-
ciency or severe prostration or hyperparasitemia > 10% as 
assessed by thick blood smears.
PCR assessing plasmodium DNA extracted 
from the blood cell fraction
A conventional genus-specific malaria PCR, targeting the 
Cytochrome b gene on the mitochondrial genome, was per-
formed on the extracted DNA from EDTA blood cell frac-
tions. For positive samples the Plasmodium species was 
determined by conventional species-specific 18S PCR or 
divergent results by sequencing [14].
Quantitative PCR assessing P. falciparum DNA 
directly from plasma
The concentration of P. falciparum DNA in plasma 
was measured by quantitative real-time PCR (qPCR) as 
described elsewhere [16] using Primer Pf-1 (5′-ATT GCT 
TTT GAG AGG TTT TGT TAC TTT-3′), primer Pf-2 (5′-
GCT GTA GTA TTC AAA CAC AAT GAA CTC AA-3′) 
and probe Pf (5′-CAT AAC AGA CGG GTA GTC AT-3′) 
(Applied Biosystems, Cheshire, UK). Each PCR test was 
performed in a 10-µL reaction mixture and qPCR assay 
was performed using a LightCycler 480 Instrument II 
(Roche Diagnostics, Mannheim, Germany). All samples 
were run on LightCycler® 480 Multiwell Plate 384, white 
(Roche), and sealed with LightCycler® 480 Sealing Foil 
(Roche). Each run included a positive control and multiple 
no-template controls. DNA extracted from an external ref-
erence material P. falciparum (US 03 F Benin I), contain-
ing exclusively ring stage parasites in a concentration of 
2000 p/μL, was used for dilution series, fivefold, to prepare 
standard curve for estimating efficiency of the PCR and for 
quantification. DNA quantity for samples with P. falcipa-
rum DNA less than the Limit of Quantification (LOQ) was 
set to be equal to or less than the LOQ (estimated to ≤ 6.4 
Table 1  Clinical characteristics of adult inpatients with falciparum malaria (n = 131) with ( +) and without (–) HIV co-infection
a Values in mean (min–max) or number and percentage except
b One patient missing
c Which is in median and IQR interquartile range (25 and 75-percentiles)
d n = 93
Characteristicsa HIV + (n = 70) HIV− (n = 61)
Uncomplicated (n = 13) Severe (n = 57) Uncomplicated (n = 33) Severe (n = 28)
Age, years 38 (26–56) 40 (20–65) 39 (18–79) 41 (20–65)
Female, sex 6 (46%) 29 (51%) 13 (39%) 12 (43%)
Haemoglobin, g/dL 10.8 (7.7–13.8) 9.0 (2.5–15.7) 11.5 (5.6–15.7) 10.8 (3.2–17.0)
Platelets, × 109/L 97 (23–205) 92 (8–330) 124 (21–324) 124 (11–452)
Se-Creatinine, µmol/L 101 (71–146) 257 (62–1529) 108 (57–203) 149 (72–357)
Malaria Rapid Test pos 12 (92%) 46 (81%) 32 (97%) 20 (71%)
Microscopy pos 10 (77%) 46 (81%) 28 (85%) 22 (79%)
Qual. blood cell mal. PCR pos 13 (100%) 56 (98%)b 32 (97%) 27 (96%)
Quant. plasma mal. PCR pos 8 (62%) 41 (72%)2) 22 (67%) 22 (79%)
Plasma P.falciparum DNA conc.c
 Mean genom./µL 82 (6–404) 1063 (6–17050) 125 (6–1210) 3965 (6–106500)
 Median genom./µLd 26 (6–142) 48 (6–379) 11 (6–68) 43 (10–224)
Respiratory rate 21 (18–28) 26 (16–44) 20 (12–28) 25 (16–68)
BP systolic, mmHg 122 (100–170) 113 (80–170) 125 (90–240) 119 (70–160)
Bleeding disturbance/haemolysis 0 9 0 1
Died 0 9 0 1
370 A. Berg et al.
1 3
parasites/µL). Samples with a P. falciparum DNA concen-
tration higher than the most concentrated standard were 
diluted and qPCR repeated. The qPCR was also repeated 
for samples with weak positive or uncertain results. The 
efficiency (using the formula E = 10–1/slope – 1) was 91.2%, 
and Error value (E) of the assay 0.012. A unidirectional 
workflow pre- to post-PCR was enforced, and preparation 
of PCR reaction mixture, DNA preparations and PCR 
were carried out in facilities physically separated from 
each other.
Statistics
Descriptive statistics are presented as mean values, ranges 
(min–max), medians, interquartile ranges (IQR; 25–75 per-
centile), and as counts and percentages. Histograms and Box 
plots were used for illustration. Comparison of patients with 
severe malaria as assessed by WHO criteria with and without 
positive qPCR in plasma was done with Chi-squared tests 
for dichotomous variables and Mann Whitney test for con-
tinuous variables. Association between patients with severe 
malaria and plasma qPCR, age, sex and HIV co-infection 
was evaluated with binary logistic regression analysis with 
95% confidence intervals (CI) and p values from Wald tests. 
For the regression analysis, malaria qPCR values were  log10 
transformed and the assumption of linearity of the effect 
of log qPCR was tested with flexible modelling (fractional 
polynomials) in Stata version 16.0, the rest of the statistical 
analyses were performed in IBM SPSS v. 24.
Results
Previous study: patient population
The patient population is described earlier [12]. In sum-
mary, 131 patients had P. falciparum malaria, defined as 
positive qualitative malaria PCR in whole blood (n = 129) 
or positive thick slide and rapid test when qualitative PCR 
was not performed (n = 2). Only two patients had co-infec-
tion with P. vivax and P. malariae, respectively. Of the 131 
falciparum malaria patients, there were 10 fatalities (8%), 
whereof nine were HIV positive. Owing to the low number 
of fatalities, mortality was not evaluated in further analy-
ses. Seventy patients (53%) were co-infected with HIV, and 
there was a higher proportion of severe malaria cases among 
these (81%) than among the HIV negative patients (46%) 
(p < 0.001) [12]. Only 20 of the HIV patients (29%) were 
aware of their HIV status before admission, of which 13 
were on antiretroviral therapy, whereof nine had effective 
treatment defined as undetectable HIV-RNA in plasma.
Present study: quantitative malaria PCR in plasma
Malaria qPCR in plasma was positive for 93 of the 131 
patients (71%). Of the 131 patients with positive qualitative 
P. falciparum PCR in blood cells, there was no significant 
difference between the 93 patients with positive qPCR in 
plasma and the 38 patients without, in relation to HIV status 
(71 vs. 72%, p = 0.89) nor to malaria severity (74 vs. 67%, 
p = 0.37). All the ten fatalities had severe malaria and the 
eight of them that had qPCR done, were all positive. Clinical 
characteristics are shown in Table 1.
The quantitative plasma parasitemia distribution is seen 
in Fig. 1.
Plasma parasitemia as assessed by qPCR in relation 
to disease severity and HIV co‑infection
There was a significant difference in the qPCR between 
patients with severe (n = 63) and uncomplicated malaria 
(n = 30) among the 93 patients with positive plasma 
qPCR (p = 0.030) (Fig. 2), with median (min–max) 143 
(6–106,500) genomes/µL versus 55 (6–1210) genomes/µL. 
On the other hand, 26% (22/85) of the patients with severe 
malaria had negative quantitative plasma PCR, and those 
patients had significant more frequent severe anaemia com-
pared to the ones with positive qPCR (p < 0.001). The severe 
malaria patients with positive plasma qPCR had significant 
more frequent severe liver failure and hyperparasitemia 
as assessed by thick blood smears, and more pronounced 
thrombocytopenia (Table 2). 
In binary logistic regression analyses the strongest predic-
tor for severe malaria was HIV co-infection with p < 0.001 
and an OR of 5.36, indicating that a HIV co-infected malaria 
Fig. 1  Distribution of plasma parasitemia as assessed by qPCR in 
patients with falciparum malaria on admission (n = 93, including 
deaths)
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patient is about five times more likely to develop severe 
malaria than a HIV negative patient, adjusting for age, sex 
and qPCR (Table 3). Plasma qPCR as surrogate marker 
for plasma parasitemia was associated with severe malaria 
(p = 0.037), but this association was attenuated when adjust-
ing for age, sex and HIV co-infection (p = 0.055), even if the 
OR was about the same before and after these adjustments 
(OR 1.41 and 1.43, respectively). The difference in plasma 
qPCR between HIV positive (n = 49) and HIV negative 
patients (n = 44) was not significant (143 [37–593] genomes/
µL vs. 55 [12–224] genomes/µL, HIV-seropositive and HIV-
seronegative, respectively, p = 0.068).
No significant differences according to disease severity 
was found in the 131 malaria patients by the use of posi-
tive thick blood smears (p = 0.97) or malaria antigen test 
(p = 0.062).
Discussion
Previously, a sub-study of the AQUAMAT multicentre study 
of artesunate versus quinine treatment for severe malaria 
[5] reported an association between disease severity and P. 
falciparum levels as assessed by qPCR in plasma in adult 
patients from Bangladesh and India and in children from 
Tanzania and Mozambique. The present study is, however, 
the first report on qPCR assessment in patients with falcipa-
rum malaria in African adults, and importantly, the present 
study also included patients co-infected with HIV. Similar 
Fig. 2  The qPCR related to severity and HIV co-infection (n = 93, 
including deaths)
Table 2  Comparison of severe malaria patients with and without 
qPCR (n = 85)
The data are percentage (proportion of patients with given condition/
the patients observed), except for the platelets given in mean (min–
max)
a The p-values are from Chi-squared tests (dichotomous data) and 
Mann–Whitney test (platelets)
b Defined as Hb < 5 g/dL
c Platelets, × 109/L
d Defined as Creatinine > 265µmol/L
e Defined as respiratory rate > 30/min or CXR with respiratory insuf-
ficiency
f Defined as Se-glucosis < 2.2mmol/L
g Systolic blood pressure < 80 mmHg
h Bleeding disturbance or hemolysis
i Glasgow Coma Scale < 11 and/or convulsions
j Microscopy of thick slide with parasitemia > 4 + 
k Bilirubin > 50 µmol/L and/or jaundice
n Plasma-PCR pos Plasma-PCR neg pa
63 22
Severe  anaemiab 5 (3/59) 45 (10/22)  < 0.001
Plateletsc 84 (8–319) 151 (17–452) 0.002
Severe renal  failured 24 (13/54) 32 (6/19) 0.52
Severe respiratory 
 failuree
25 (16/63) 27 (6/22) 0.86
Hypoglycaemiaf 9 (5/54) 0 (0/19) 0.17
Hypotensiong 2 (1/54) 0 (0/21) 0.53
Coagulation 
 disturbanceh
8 (5/63) 23 (5/22) 0.064
Cerebral  malariai 37 (23/63) 27 (6/22) 0.43
Hyperparasitemiaj 76 (45/59) 21 (4/19)  < 0.001
Liver  failurek 25 (16/63) 0 (0/22) 0.009
Fatalities 13 (8/63) 10 (2/21) 0.70
Table 3  Association between malaria severity and qPCR, age, sex 
and HIV co-infection in 131 malaria patients
Results from binary logistic regression analysis
OR odds ratio, CI  confidence interval
a The p values are from Wald tests
Characteristics Unadjusted Adjusted
OR (95% CI) p  valuea OR (95% CI) p value
Age 1.01 (0.99, 
1.04)
0.40 1.01 (0.98, 
1.04)
0.66
Sex 0.76 (0.37, 
1.56)
0.45 0.72 (0.31, 
1.67)
0.45
HIV 5.17 (2.36, 
11.33)
 < 0.001 5.37 (2.37, 
12.16)
 < 0.001
Log qPCR 1.41 (1.02, 
1.96)
0.037 1.43 (0.99, 
2.07)
0.055
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to the Aquamat sub-study there was a significant associa-
tion between disease severity and qPCR not observed for 
positive thick blood smears and malaria antigen test. How-
ever, whereas the Aquamat sub-study did not consider HIV 
co-infection, we found that the association between plasma 
parasitemia as assessed by qPCR and severe malaria was 
attenuated and not significant after adjusting for age, sex 
and HIV co-infection, even if the OR remained about the 
same. This is probably due to the relatively low number of 
patients in each subgroup. An alternative explanation could 
be that HIV co-infection increases the malaria disease sever-
ity through other mechanism not directly related to increas-
ing the malaria qPCR in plasma. This is less plausible since 
other investigators found increased malaria parasitemia as 
least in whole blood as assessed by different methods includ-
ing blood smears in relation to HIV infection [11, 17, 18]. 
Second, the observed increased severity may be due to other 
concomitant HIV-associated opportunistic co-infections dif-
ficult to diagnose in this relative low resource setting [3, 19]. 
This may have been the case, considering the substantial 
overlap of HIV and malaria prevalence in this region. On 
the other hand, with increasing coverage of antiretroviral 
therapy (ART) in sub-Saharan Africa, the mentioned bias 
may be diminished by examining this interaction in a larger 
group of asymptomatic HIV infected patients with fully sup-
pressed viral load on anti-retroviral therapy.
Twenty-six percent of the patients with severe malaria (22 
of 85) had parasitemia below the limit of detection for the 
quantitative plasma PCR. As the parasite has erythrocytes as 
its major target cells in whole blood, it is not surprising that 
PCR analyses from whole blood are in general more sensi-
tive than PCR analyses from plasma. A former analysis by 
RT-PCR for the 18S ribosomal gene for falciparum malaria 
in small children also found 3.5-fold higher parasitemia in 
whole blood compared to plasma [20]. The malaria PCR 
from whole blood is more sensitive in diagnosing low-level 
parasitemia, as for instance in vaccine research, but harbours 
the risk of over-diagnosing disease in asymptomatic carri-
ers [21]. This explains the pronounced difference in plasma 
and red cell parasitemia, but does not explain the 22 patients 
diagnosed as severe malaria without having positive plasma 
qPCR. The severe malaria patients with plasma qPCR had 
significant more frequent severe liver failure and hyperpara-
sitemia as assessed by thick blood smears, and also thrombo-
cytopenia, but no significant difference in the other criteria 
for severe malaria.
This study cannot confirm nor oppose the results of the 
Aquamat sub-study. On the other hand, this study under-
lines the importance of considering HIV co-infection in 
malaria. With the great geographic overlap of HIV and 
malaria together with the increased risk of severe malaria, 
HIV status should always be included. There is need for 
further studies to clarify if qPCR may be a useful method 
for quantification of parasite load in patients with falciparum 
malaria as an indication of very severe malaria. Provided 
that the sensitivity of method is improved, it is possible that 
qPCR will have a future potential for evaluating disease 
severity in falciparum malaria, and there is a need for fur-
ther and larger studies to clarify whether quantitative qPCR 
may be an indicator of clinical disease severity in falciparum 
malaria.
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